{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:41:15Z","timestamp":1787002875219,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:00:00Z","timestamp":1663027200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PO2366\/2\u20131"],"award-info":[{"award-number":["PO2366\/2\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["387509280"],"award-info":[{"award-number":["387509280"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1350, TP C4"],"award-info":[{"award-number":["SFB 1350, TP C4"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hereditary chronic kidney disease (CKD) appears to be more frequent than the clinical perception. Exome sequencing (ES) studies in CKD cohorts could identify pathogenic variants in ~10% of individuals. Tubulointerstitial kidney diseases, showing no typical clinical\/histologic finding but tubulointerstitial fibrosis, are particularly difficult to diagnose. We used a targeted panel (29 genes) and\n                    <jats:italic>MUC1<\/jats:italic>\n                    -SNaPshot to sequence 271 DNAs, selected in defined disease entities and age cutoffs from 5217 individuals in the German Chronic Kidney Disease cohort. We identified 33 pathogenic variants. Of these 27 (81.8%) were in\n                    <jats:italic>COL4A3\/4\/5<\/jats:italic>\n                    , the largest group being 15\n                    <jats:italic>COL4A5<\/jats:italic>\n                    variants with nine unrelated individuals carrying c.1871G&gt;A, p.(Gly624Asp). We found three cysteine variants in\n                    <jats:italic>UMOD<\/jats:italic>\n                    , a novel missense and a novel splice variant in\n                    <jats:italic>HNF1B<\/jats:italic>\n                    and the homoplastic\n                    <jats:italic>MTTF<\/jats:italic>\n                    variant m.616T&gt;C. Copy-number analysis identified a heterozygous\n                    <jats:italic>COL4A5<\/jats:italic>\n                    deletion, and a\n                    <jats:italic>HNF1B<\/jats:italic>\n                    duplication\/deletion, respectively. Overall, pathogenic variants were present in 12.5% (34\/271) and variants of unknown significance in 9.6% (26\/271) of selected individuals. Bioinformatic predictions paired with gold standard diagnostics for\n                    <jats:italic>MUC1<\/jats:italic>\n                    (SNaPshot) could not identify the typical cytosine duplication (\u201cc.428dupC\u201d) in any individual, implying that ADTKD-\n                    <jats:italic>MUC1<\/jats:italic>\n                    is rare. Our study shows that &gt;10% of selected individuals carry disease-causing variants in genes partly associated with tubulointerstitial kidney diseases.\n                    <jats:italic>COL4A3\/4\/5<\/jats:italic>\n                    genes constitute the largest fraction, implying they are regularly overlooked using clinical Alport syndrome criteria and displaying the existence of phenocopies. We identified variants easily missed by some ES pipelines. The clinical filtering criteria applied enriched for an underlying genetic disorder.\n                  <\/jats:p>","DOI":"10.1038\/s41431-022-01177-9","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T00:02:44Z","timestamp":1663027364000},"page":"1413-1422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study"],"prefix":"10.1038","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3679-1081","authenticated-orcid":false,"given":"Bernt","family":"Popp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6099-7066","authenticated-orcid":false,"given":"Arif B.","family":"Ekici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl X.","family":"Knaup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Uebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonghun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Bafna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-8264","authenticated-orcid":false,"given":"Heike","family":"Meiselbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6301-6363","authenticated-orcid":false,"given":"Andr\u00e9","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4992-3132","authenticated-orcid":false,"given":"Michael","family":"Wiesener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,13]]},"reference":[{"key":"1177_CR1","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1016\/S0140-6736(14)60659-0","volume":"383","author":"O Devuyst","year":"2014","unstructured":"Devuyst O, Knoers NVAM, Remuzzi G, Schaefer F. Board of the Working Group for Inherited Kidney Diseases of the European Renal Association and European Dialysis and Transplant Association. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet. 2014;383:1844\u201359. https:\/\/doi.org\/10.1016\/S0140-6736(14)60659-0","journal-title":"Lancet"},{"key":"1177_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7326\/M18-1241","volume":"170","author":"HM Rasouly","year":"2019","unstructured":"Rasouly HM, Groopman EE, Heyman-Kantor R, Fasel DA, Mitrotti A, Westland R, et al. The burden of candidate pathogenic variants for kidney and genitourinary disorders emerging from exome sequencing. Ann Intern Med. 2019;170:11. https:\/\/doi.org\/10.7326\/M18-1241","journal-title":"Ann Intern Med"},{"key":"1177_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1056\/NEJMoa1806891","volume":"380","author":"EE Groopman","year":"2019","unstructured":"Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med. 2019;380:142\u201351. https:\/\/doi.org\/10.1056\/NEJMoa1806891","journal-title":"N Engl J Med"},{"key":"1177_CR4","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.2215\/CJN.15141219","volume":"15","author":"E Cocchi","year":"2020","unstructured":"Cocchi E, Nestor JG, Gharavi AG. Clinical genetic screening in adult patients with kidney disease. Clin J Am Soc Nephrol. 2020;15:1497\u2013510. https:\/\/doi.org\/10.2215\/CJN.15141219","journal-title":"Clin J Am Soc Nephrol"},{"key":"1177_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.kint.2020.03.031","volume":"98","author":"T Hays","year":"2020","unstructured":"Hays T, Groopman EE, Gharavi AG. Genetic testing for kidney disease of unknown etiology. Kidney Int. 2020;98:590\u2013600. https:\/\/doi.org\/10.1016\/j.kint.2020.03.031","journal-title":"Kidney Int"},{"key":"1177_CR6","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ki.2015.28","volume":"88","author":"KU Eckardt","year":"2015","unstructured":"Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, et al. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management\u2014a KDIGO consensus report. Kidney Int. 2015;88:676\u201383. https:\/\/doi.org\/10.1038\/ki.2015.28","journal-title":"Kidney Int"},{"key":"1177_CR7","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41572-019-0109-9","volume":"5","author":"O Devuyst","year":"2019","unstructured":"Devuyst O, Olinger E, Weber S, Eckardt KU, Kmoch S, Rampoldi L, et al. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Prim. 2019;5:60. https:\/\/doi.org\/10.1038\/s41572-019-0109-9","journal-title":"Nat Rev Dis Prim."},{"key":"1177_CR8","doi-asserted-by":"publisher","unstructured":"Connor TM, Hoer S, Mallett A, Gale DP, Gomez-Duran A, Posse V, et al. Mutations in mitochondrial DNA causing tubulointerstitial kidney disease. Larsson NG, ed. PLOS Genet. 2017;13:e1006620. https:\/\/doi.org\/10.1371\/journal.pgen.1006620","DOI":"10.1371\/journal.pgen.1006620"},{"key":"1177_CR9","doi-asserted-by":"publisher","unstructured":"Braun DA, Hildebrandt F. Ciliopathies. Cold Spring Harb Perspect Biol. 2017;9. https:\/\/doi.org\/10.1101\/cshperspect.a028191","DOI":"10.1101\/cshperspect.a028191"},{"key":"1177_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/ng.2543","volume":"45","author":"A Kirby","year":"2013","unstructured":"Kirby A, Gnirke A, Jaffe DB, Bare\u0161ov\u00e1 V, Pochet N, Blumenstiel B, et al. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013;45:299\u2013303. https:\/\/doi.org\/10.1038\/ng.2543","journal-title":"Nat Genet"},{"key":"1177_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/ki.2014.72","volume":"86","author":"AB Ekici","year":"2014","unstructured":"Ekici AB, Hackenbeck T, Morini\u00e8re V, Pannes A, Buettner M, Uebe S, et al. Renal fibrosis is the common feature of autosomal dominant tubulointerstitial kidney diseases caused by mutations in mucin 1 or uromodulin. Kidney Int. 2014;86:589\u201399. https:\/\/doi.org\/10.1038\/ki.2014.72","journal-title":"Kidney Int"},{"key":"1177_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s00467-018-3990-7","volume":"34","author":"S Ferr\u00e8","year":"2019","unstructured":"Ferr\u00e8 S, Igarashi P. New insights into the role of HNF-1\u03b2 in kidney (patho)physiology. Pediatr Nephrol. 2019;34:1325\u201335. https:\/\/doi.org\/10.1007\/s00467-018-3990-7","journal-title":"Pediatr Nephrol"},{"key":"1177_CR13","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/ndt\/gfu294","volume":"30","author":"S Titze","year":"2015","unstructured":"Titze S, Schmid M, K\u00f6ttgen A, Busch M, Floege J, Wanner C, et al. Disease burden and risk profile in referred patients with moderate chronic kidney disease: composition of the German Chronic Kidney Disease (GCKD) cohort. Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc 2015;30:441\u201351. https:\/\/doi.org\/10.1093\/ndt\/gfu294","journal-title":"Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"1177_CR14","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1093\/ndt\/gfr456","volume":"27","author":"KU Eckardt","year":"2012","unstructured":"Eckardt KU, Barthlein B, Baid-Agrawal S, Beck A, Busch M, Eitner F, et al. The German Chronic Kidney Disease (GCKD) study: design and methods. Nephrol Dial Transpl. 2012;27:1454\u201360. https:\/\/doi.org\/10.1093\/ndt\/gfr456","journal-title":"Nephrol Dial Transpl"},{"key":"1177_CR15","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/hmg\/8.11.2001","volume":"8","author":"TH Lindner","year":"1999","unstructured":"Lindner TH, Njolstad PR, Horikawa Y, Bostad L, Bell GI, Sovik O. A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet. 1999;8:2001\u20138. https:\/\/doi.org\/10.1093\/hmg\/8.11.2001","journal-title":"Hum Mol Genet"},{"key":"1177_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ajhg.2009.07.010","volume":"85","author":"M Zivn\u00e1","year":"2009","unstructured":"Zivn\u00e1 M, H\u016flkov\u00e1 H, Matignon M, Hodanov\u00e1 K, Vylet\u2019al P, Kalb\u00e1cov\u00e1 M, et al. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. Am J Hum Genet. 2009;85:204\u201313. https:\/\/doi.org\/10.1016\/j.ajhg.2009.07.010","journal-title":"Am J Hum Genet"},{"key":"1177_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.ajhg.2016.05.028","volume":"99","author":"NA Bolar","year":"2016","unstructured":"Bolar NA, Golzio C, \u017divn\u00e1 M, Hayot G, Van Hemelrijk C, Schepers D, et al. Heterozygous loss-of-function SEC61A1 Mutations cause autosomal-dominant tubulo-interstitial and glomerulocystic kidney disease with anemia. Am J Hum Genet. 2016;99:174\u201387. https:\/\/doi.org\/10.1016\/j.ajhg.2016.05.028","journal-title":"Am J Hum Genet"},{"key":"1177_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/jmg.39.12.882","volume":"39","author":"TC Hart","year":"2002","unstructured":"Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, et al. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. J Med Genet. 2002;39:882\u201392. https:\/\/doi.org\/10.1136\/jmg.39.12.882","journal-title":"J Med Genet"},{"key":"1177_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-22428-0","volume":"8","author":"A Wenzel","year":"2018","unstructured":"Wenzel A, Altmueller J, Ekici AB, Popp B, Stueber K, Thiele H, et al. Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations. Sci Rep. 2018;8:4170. https:\/\/doi.org\/10.1038\/s41598-018-22428-0","journal-title":"Sci Rep"},{"key":"1177_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med J. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med J."},{"key":"1177_CR21","doi-asserted-by":"publisher","unstructured":"Popp Bernt. Data files for manuscript \u201cPrevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study.\u201d Published online September 19, 2021. https:\/\/doi.org\/10.5281\/ZENODO.5516388","DOI":"10.5281\/ZENODO.5516388"},{"key":"1177_CR22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1159\/000504412","volume":"144","author":"R Lorenz","year":"2020","unstructured":"Lorenz R, Ahting U, Betzler C, Heimering S, Borggr\u00e4fe I, Lange-Sperandio B. Homoplasmy of the mitochondrial DNA mutation m.616T>C leads to mitochondrial tubulointerstitial kidney disease and encephalopathia. Nephron. 2020;144:156\u201360. https:\/\/doi.org\/10.1159\/000504412","journal-title":"Nephron"},{"key":"1177_CR23","first-page":"207","volume":"17","author":"A Pierides","year":"2013","unstructured":"Pierides A, Voskarides K, Kkolou M, Hadjigavriel M. Deltas C. X-linked, COL4A5 hypomorphic Alport mutations such as G624D and P628L may only exhibit thin basement membrane nephropathy with microhematuria and late onset kidney failure. Hippokratia. 2013;17:207\u201313.","journal-title":"Hippokratia."},{"key":"1177_CR24","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.kint.2020.10.040","volume":"99","author":"AM \u017burowska","year":"2021","unstructured":"\u017burowska AM, Bielska O, Daca-Roszak P, Jankowski M, Szczepa\u0144ska M, Roszkowska-Bjanid D, et al. Mild X-linked Alport syndrome due to the COL4A5 G624D variant originating in the Middle Ages is predominant in Central\/East Europe and causes kidney failure in midlife. Kidney Int. 2021;99:1451\u20138. https:\/\/doi.org\/10.1016\/j.kint.2020.10.040","journal-title":"Kidney Int"},{"key":"1177_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3389\/fped.2019.00485","volume":"7","author":"EP Macheroux","year":"2019","unstructured":"Macheroux EP, Braunisch MC, Pucci Pegler S, Satanovskij R, Riedhammer KM, G\u00fcnthner R, et al. The hypomorphic variant p.(Gly624Asp) in COL4A5 as a possible cause for an unexpected severe phenotype in a family with X-linked alport syndrome. Front Pediatr. 2019;7:485. https:\/\/doi.org\/10.3389\/fped.2019.00485","journal-title":"Front Pediatr"},{"key":"1177_CR26","doi-asserted-by":"publisher","unstructured":"Boeckhaus J, Hoefele J, Riedhammer KM, Nagel M, Beck B, Choi M, et al. Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc\u2014Eur Ren Assoc. Published online January 12, 2022:gfac006. https:\/\/doi.org\/10.1093\/ndt\/gfac006","DOI":"10.1093\/ndt\/gfac006"},{"key":"1177_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa1516767","volume":"376","author":"JE Posey","year":"2017","unstructured":"Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, Coban Akdemir ZH, et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N Engl J Med. 2017;376:21\u201331. https:\/\/doi.org\/10.1056\/NEJMoa1516767","journal-title":"N Engl J Med"},{"key":"1177_CR28","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","volume":"13","author":"RJ Glassock","year":"2017","unstructured":"Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104\u201314. https:\/\/doi.org\/10.1038\/nrneph.2016.163","journal-title":"Nat Rev Nephrol"},{"key":"1177_CR29","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/S0140-6736(17)30788-2","volume":"390","author":"A Levin","year":"2017","unstructured":"Levin A, Tonelli M, Bonventre J, Coresh J, Donner JA, Fogo AB, et al. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy. Lancet. 2017;390:1888\u2013917. https:\/\/doi.org\/10.1016\/S0140-6736(17)30788-2","journal-title":"Lancet"},{"key":"1177_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneph.2015.205","volume":"12","author":"A Vivante","year":"2016","unstructured":"Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol. 2016;12:133\u201346. https:\/\/doi.org\/10.1038\/nrneph.2015.205","journal-title":"Nat Rev Nephrol"},{"key":"1177_CR31","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/ndt\/gfab218","volume":"37","author":"N Knoers","year":"2022","unstructured":"Knoers N, Antignac C, Bergmann C, Dahan K, Giglio S, Heidet L, et al. Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice. Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc 2022;37:239\u201354. https:\/\/doi.org\/10.1093\/ndt\/gfab218","journal-title":"Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"1177_CR32","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cge.13077","volume":"92","author":"L Papazachariou","year":"2017","unstructured":"Papazachariou L, Papagregoriou G, Hadjipanagi D, Demosthenous P, Voskarides K, Koutsofti C, et al. Frequent COL4 mutations in familial microhematuria accompanied by later-onset Alport nephropathy due to focal segmental glomerulosclerosis. Clin Genet. 2017;92:517\u201327. https:\/\/doi.org\/10.1111\/cge.13077","journal-title":"Clin Genet"},{"key":"1177_CR33","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.ekir.2020.04.011","volume":"5","author":"Y Li","year":"2020","unstructured":"Li Y, Groopman EE, D\u2019Agati V, Prakash S, Zhang J, Mizerska-Wasiak M, et al. Type IV collagen mutations in familial IgA nephropathy. Kidney Int Rep. 2020;5:1075\u20138. https:\/\/doi.org\/10.1016\/j.ekir.2020.04.011","journal-title":"Kidney Int Rep"},{"key":"1177_CR34","doi-asserted-by":"publisher","first-page":"100","DOI":"10.7326\/M17-1319","volume":"168","author":"S Lata","year":"2018","unstructured":"Lata S, Marasa M, Li Y, Fasel DA, Groopman E, Jobanputra V, et al. Whole-exome sequencing in adults with chronic kidney disease: a pilot study. Ann Intern Med. 2018;168:100. https:\/\/doi.org\/10.7326\/M17-1319","journal-title":"Ann Intern Med"},{"key":"1177_CR35","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1053\/j.ajkd.2019.12.008","volume":"76","author":"KM Riedhammer","year":"2020","unstructured":"Riedhammer KM, Braunisch MC, G\u00fcnthner R, Wagner M, Hemmer C, Strom TM, et al. Exome sequencing and identification of phenocopies in patients with clinically presumed hereditary nephropathies. Am J Kidney Dis. 2020;76:460\u201370. https:\/\/doi.org\/10.1053\/j.ajkd.2019.12.008","journal-title":"Am J Kidney Dis"},{"key":"1177_CR36","doi-asserted-by":"publisher","unstructured":"Wopperer FJ, Knaup KX, Stanzick KJ, Schneider K, Jobst-Schwan T, Ekici AB, et al. Diverse molecular causes of unsolved autosomal dominant tubulointerstitial kidney diseases. Kidney Int. Published online 2022:S0085253822003842. https:\/\/doi.org\/10.1016\/j.kint.2022.04.031","DOI":"10.1016\/j.kint.2022.04.031"},{"key":"1177_CR37","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ndt\/4.11.943","volume":"4","author":"R Waldherr","year":"1989","unstructured":"Waldherr R, Rambausek M, Duncker WD, Ritz E. Frequency of mesangial IgA deposits in a non-selected autopsy series. Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc 1989;4:943\u20136. https:\/\/doi.org\/10.1093\/ndt\/4.11.943","journal-title":"Nephrol Dial Transpl Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"1177_CR38","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1136\/jcp.46.7.607","volume":"46","author":"J Varis","year":"1993","unstructured":"Varis J, Rantala I, Pasternack A, Oksa H, J\u00e4ntti M, Paunu ES, et al. Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. J Clin Pathol. 1993;46:607\u201310. https:\/\/doi.org\/10.1136\/jcp.46.7.607","journal-title":"J Clin Pathol"},{"key":"1177_CR39","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1046\/j.1523-1755.63.6s.2.x","volume":"63","author":"K Suzuki","year":"2003","unstructured":"Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int. 2003;63:2286\u201394. https:\/\/doi.org\/10.1046\/j.1523-1755.63.6s.2.x","journal-title":"Kidney Int"},{"key":"1177_CR40","doi-asserted-by":"publisher","unstructured":"Knaup KX, B\u00fcttner-Herold M, Popp B, Stoeckert J, Schiffer M, Schueler M, et al. The dilemma of regularly missed diagnoses: ADTKD. Arch Clin Med Case Rep. 2019;03. https:\/\/doi.org\/10.26502\/acmcr.96550127","DOI":"10.26502\/acmcr.96550127"},{"key":"1177_CR41","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.kint.2020.04.038","volume":"98","author":"E Olinger","year":"2020","unstructured":"Olinger E, Hofmann P, Kidd K, Dufour I, Belge H, Schaeffer C, et al. Clinical and genetic spectra of autosomal dominant tubulointerstitial kidney disease due to mutations in UMOD and MUC1. Kidney Int. 2020;98:717\u201331. https:\/\/doi.org\/10.1016\/j.kint.2020.04.038","journal-title":"Kidney Int"},{"key":"1177_CR42","doi-asserted-by":"publisher","first-page":"527","DOI":"10.2215\/CJN.06380613","volume":"9","author":"AJ Bleyer","year":"2014","unstructured":"Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, et al. Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol. 2014;9:527\u201335. https:\/\/doi.org\/10.2215\/CJN.06380613","journal-title":"Clin J Am Soc Nephrol."},{"key":"1177_CR43","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1080\/0886022X.2019.1655452","volume":"41","author":"S Cormican","year":"2019","unstructured":"Cormican S, Connaughton DM, Kennedy C, Murray S, \u017divn\u00e1 M, Kmoch S, et al. Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland. Ren Fail. 2019;41:832\u201341. https:\/\/doi.org\/10.1080\/0886022X.2019.1655452","journal-title":"Ren Fail"},{"key":"1177_CR44","doi-asserted-by":"publisher","unstructured":"Miller DT, Lee K, Gordon AS, Amendola LM, Adelman K, Bale SJ, et al. Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med Off. Published online May 20, 2021. https:\/\/doi.org\/10.1038\/s41436-021-01171-4","DOI":"10.1038\/s41436-021-01171-4"},{"key":"1177_CR45","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1681\/ASN.2018030245","volume":"29","author":"KX Knaup","year":"2018","unstructured":"Knaup KX, Hackenbeck T, Popp B, Stoeckert J, Wenzel A, B\u00fcttner-Herold M, et al. Biallelic expression of Mucin-1 in autosomal dominant tubulointerstitial kidney disease: implications for nongenetic disease recognition. J Am Soc Nephrol. 2018;29:2298\u2013309. https:\/\/doi.org\/10.1681\/ASN.2018030245","journal-title":"J Am Soc Nephrol"},{"key":"1177_CR46","doi-asserted-by":"publisher","first-page":"W70","DOI":"10.1093\/nar\/gkn188","volume":"36","author":"AR Gruber","year":"2008","unstructured":"Gruber AR, Lorenz R, Bernhart SH, Neub\u00f6ck R, Hofacker IL. The Vienna RNA websuite. Nucleic Acids Res. 2008;36:W70\u201374. https:\/\/doi.org\/10.1093\/nar\/gkn188","journal-title":"Nucleic Acids Res"},{"key":"1177_CR47","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/nar\/gkl927","volume":"35","author":"E Ruiz-Pesini","year":"2007","unstructured":"Ruiz-Pesini E, Lott MT, Procaccio V, Poole JC, Brandon MC, Mishmar D, et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res. 2007;35:823\u20138. https:\/\/doi.org\/10.1093\/nar\/gkl927","journal-title":"Nucleic Acids Res"},{"key":"1177_CR48","doi-asserted-by":"publisher","unstructured":"Park J, Bakhtiari M, Popp B, Wiesener M, Bafna V. Detecting tandem repeat variants in coding regions using code-adVNTR. iScience. 2022;25:104785. https:\/\/doi.org\/10.1016\/j.isci.2022.104785","DOI":"10.1016\/j.isci.2022.104785"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01177-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01177-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T20:05:57Z","timestamp":1669838757000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-022-01177-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1177"],"URL":"https:\/\/doi.org\/10.1038\/s41431-022-01177-9","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.09.29.21264100","asserted-by":"object"}]},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,13]]},"assertion":[{"value":"3 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study adheres to the principles set out in the Declaration of Helsinki. The probands included in our study were filtered using the database of the German Chronic Kidney Disease (GCKD) cohort which enrolled 5217 exclusively Caucasian individuals. The GCKD study is registered as a national clinical study (DRKS 00003971) and was approved by local ethics review boards of all participating institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}